SCHEMBL5111320

SCHEMBL5111320

CCC(=O)Nc1cc(F)cc(COc2c(Cl)cc(C(=O)NCC(=O)O)cc2Cl)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
RAB9A P51151 2/20 0.39
HPGD P15428 2/20 0.39
GAA P10253 2/20 0.39
NPC1 O15118 1/20 0.39
ABL1 P00519 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
RIN1 Q13671 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
SENP5 Q96HI0 1/20 0.39
SENP2 Q9HC62 1/20 0.39
SENP1 Q9P0U3 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.37
PLAU P00749 1/20 0.36
KDM4E B2RXH2 3/20 0.36
HSD17B10 Q99714 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5722547 0.95 THRA (0.41) ALDH1A1MEN1KMT2ARAB9AHPGD
SCHEMBL5116889 0.90 SMN1; SMN2 (0.40) ALDH1A1MEN1KMT2ARAB9AHPGD
SCHEMBL5117190 0.90 MEN1 (0.40) ALDH1A1MEN1KMT2ARAB9AHPGD
SCHEMBL5105172 0.90 BRD4 (0.39) ALDH1A1MEN1KMT2ARAB9AHPGD
SCHEMBL5109500 0.89 ALDH1A1 (0.41) ALDH1A1MEN1KMT2ARAB9AHPGD
SCHEMBL4931811 0.88 THRA (0.40) ALDH1A1MEN1KMT2ARAB9AHPGD
SCHEMBL5722552 0.88 MAPK1 (0.36) ALDH1A1MEN1KMT2ARAB9AHPGD
SCHEMBL4932562 0.87 ALDH1A1 (0.39) ALDH1A1MEN1KMT2ARAB9AHPGD
SCHEMBL5103298 0.87 RHOC (0.45) ALDH1A1MEN1KMT2ALMNASENP5
SCHEMBL5110128 0.87 SENP5 (0.40) ALDH1A1MEN1KMT2ARAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor KARO BIO AB (SE) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor TSHR, TRHR, THRA ALDH1A1 2530/4885MEN1 806/4885KMT2A 2895/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.